Expanded availability of isotope boon to neuroblastoma diagnosis.
Morrow
Thomas
T
Value-Based Health Department, Genentech Inc, USA.
D019797:3-Iodobenzylguanidine / Q000493:pharmacokinetics; D017277:Drug Approval; D006207:Half-Life; D006801:Humans; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics; D009447:Neuroblastoma / Q000000981:diagnostic imaging* / Q000378:metabolism; D009638:Norepinephrine / Q000031:analogs & derivatives; D009662:Nortropanes / Q000493:pharmacokinetics; D010673:Pheochromocytoma / Q000000981:diagnostic imaging* / Q000378:metabolism; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D014481:United States; D014486:United States Food and Drug Administration
C402415:I123-PE2I; D007457:Iodine Radioisotopes; D009662:Nortropanes; D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine; D009638:Norepinephrine